BTIG analyst Julian Harrison reiterated a Buy rating on Outlook Therapeutics (OTLK – Research Report) today and set a price target of ...

Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...

The primary objective is to evaluate the safety of CLN-978 for the treatment of active moderate to severe SLE, with secondary ...

Cullinan Therapeutics said the U.S. Food and Drug Administration approved its investigation new drug application for CLN-978, a potential treatment for lupus. The biopharmaceutical company said the ...

Inaugural Program Will Recognize Marketing Campaigns, Event Strategies and Brand Awareness Initiatives ...

Cullinan Management (CGEM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit ...

The long-term risk of distant recurrence for women with early breast cancer has declined significantly, a decades-long ...

In fact, the refreshed Cullinan – which is getting larger (23-inch) wheels, a fresh look at the front, new interior materials, and additional personalization options along with an upgraded ...

It was 10 years ago that George Cullinan first noticed an odd-looking bird on his farm in the Victorian Mallee. "The first one I found was dead in a water trough," he said. Intrigued by his morbid ...

Marburg vaccines are set to arrive in Rwanda in the coming days to help protect healthcare workers fighting an outbreak of ...

There are no specific treatments or licensed vaccines available for the Marburg virus, but a range of therapeutics are currently in development, according to the WHO. The virus was first ...

We feel now is a pretty good time to analyse Heron Therapeutics, Inc.'s (NASDAQ:HRTX) business as it appears the company may be on the cusp of a considerable accomplishment. Heron Therapeutics ...